Sequencing of bone marrow DNA may predict leukemia relapse after CAR-T therapy with sufficient time to intervene
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all ...
Dec 1, 2021
0
1